AJMC November 29, 2024
Skylar Jeremias

Sandra Cuellar, PharmD, from the University of Illinois Chicago, highlights the critical role of real-world data in shaping reimbursement models for oncology therapies and emphasizes the growing importance of patient-centered care through shared decision-making, precision medicine, and patient-reported outcomes.

The role of real-world data (RWD) and patient-centered care in oncology is evolving, said Sandra Cuellar, PharmD, clinical associate professor in the Department of Pharmacy Practice at the University of Illinois Chicago.

RWD is essential for assessing the effectiveness of high-cost cancer therapies in diverse, real-world patient populations, influencing the development of flexible reimbursement models. She also emphasizes the growing importance of patient-centered care, where patient-reported outcomes (PROs), precision medicine, and shared decision-making play a critical role in tailoring treatment options...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, Conferences / Podcast, Provider, Technology, Trends
Trust, But Verify The Data Feeding Your AI Systems
Creating Value: How Data, AI, And Apps Transform Business
Healthcare’s Data-Driven Transformation: Breaking Down Silos To Improve Efficiency
Cedars-Sinai’s New AI Chief Digs Into the Data
AI: The Battlefield In The War For Data Control

Share This Article